Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative ...

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.

Expect ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, to complete enrollment ... which are a highly toxic and pathogenic form of Aβ, ...

PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting ...

single-injection once-monthly antibody delivered subcutaneously targeting a key epitope at the N-terminus of amyloid beta (Aβ) — for treating Alzheimer’s Disease (AD). Initial phase I single ascending ...

The Mediterranean diet is a healthy eating plan based on the cultures of Mediterranean countries. It includes beverages such ...

In the early phase of Alzheimer’s disease, astrocytes are the primary source of APOE in the brain. This study examined the ...

Results indicated PMN310 was generally well-tolerated and monthly dosing can provide CSF levels adequate for target ...

BioArctic's report for the third quarter 2024 will be published on November 14 at 08.00 a.m. CET. BioArctic's report for the third quarter 2024 will be published onNovember 14at08.00 a.m. CET. This ...

scan has been proposed to detect amyloid-β (Aβ) deposition in the brain. However, this approach is costly and not ideal for the early diagnosis of Alzheimer’s disease. Blood-based Aβ measurement ...

The onset of symptoms of Alzheimer's disease can occur and worsen faster in people that also have an alcohol use disorder ...